Tamil Nadu

NITTTR Chennai is mandated to work at the intersection of Technology, Content and Pedagogy which will be accomplished with the help of Information and Communication Technologies. The expertise of the Institute will be available to the entire gamut of Technical, Vocational and Management sectors. NITTTR Chennai caters to the needs of the southern States viz., Andhra Pradesh, Karnataka, Kerala, Tamil Nadu (including Puducherry Union Territory) and Telangana which contribute to 35% of the total number of technical institutions in the Country.

The promulgation of Employees' State Insurance Act, 1948(ESI Act), by the Parliament was the first major legislation on social Security for workers in independent India. It was a time when the industry was still in a nascent stage and the country was heavily dependent on an assortment of imported goods from the developed or fast developing countries. The deployment of manpower in manufacturing processes was limited to a few select industries such as jute, textile, chemicals etc.

Arcolab is a Global Capability Center designed to provide diverse capabilities across functions and expand with SMEs, prioritizing customer centricity and delivering excellence.  A customer-centric company designed as a centre of excellence for specialised services to support numerous business needs. Arcolab is a comprehensive, customer-first company and the right fit for all pharma-related services, including technical services.

Karnataka Antibiotics and Pharmaceuticals Limited, KAPL Bengaluru is a Government of India Enterprise. Karnataka Antibiotics and Pharmaceuticals Limited is a Joint Sector Company of Government of India with shareholding from Government of Karnataka through Karnataka State Industrial Infrastructure Development Corporation KSIIDC. From a modest beginning in 1984, KAPL has grown exponentially in the areas of manufacturing and marketing of various life saving and essential drugs.

Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.

Cipla, as an organisation has been built brick-by-brick on the foundation of care. Caring For Life has always been and continues to remain, our guiding purpose. Driven by the same purpose, we have extended our presence to 80+ countries providing over 1,500 products across various therapeutic categories in 50+ dosage forms. To make healthcare more affordable globally, we are deepening our presence in the key markets of India, South Africa, the U.S. among other economies of the emerging world.

General Services Organization (GSO) is one of the constituent units of the Department of Atomic Energy, Government of India, and was setup in the year 1979. GSO is headed by Dr. B. Venkatraman, Distinguished Scientist as Director, GSO who is also Director, IGCAR.

Pfizer is the world's premier biopharmaceutical company taking new approaches to better health.  We discover, develop, manufacture and deliver quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. We also partner with healthcare providers, governments and local communities around the world to expand access to our medicines and to provide better quality health care and health system support.

Panacea Biotec is a leading research based Health Management Company, with an annual turnover of approx. Rs. 830 Crores. We are engaged in research, development, manufacture & marketing of Vaccines, Bio-Pharmaceuticals and Pharmaceuticals (Rx & OTC) of international quality and Health Services. All Panacea Biotec plants are accredited by international agencies and they follow current Good Manufacturing Practices, as per WHO guidelines.